- Home
- GEVO vs TKNO Comparison
GEVO vs TKNO Comparison
Compare GEVO & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- TKNO
- Stock Information
- Founded
- GEVO 2005
- TKNO 1996
- Country
- GEVO United States
- TKNO United States
- Employees
- GEVO N/A
- TKNO N/A
- Industry
- GEVO Major Chemicals
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- GEVO Industrials
- TKNO Health Care
- Exchange
- GEVO Nasdaq
- TKNO Nasdaq
- Market Cap
- GEVO 418.4M
- TKNO 256.9M
- IPO Year
- GEVO 2011
- TKNO 2021
- Fundamental
- Price
- GEVO $1.73
- TKNO $4.35
- Analyst Decision
- GEVO Buy
- TKNO
- Analyst Count
- GEVO 2
- TKNO 0
- Target Price
- GEVO $7.58
- TKNO N/A
- AVG Volume (30 Days)
- GEVO 9.4M
- TKNO 224.0K
- Earning Date
- GEVO 08-11-2025
- TKNO 08-07-2025
- Dividend Yield
- GEVO N/A
- TKNO N/A
- EPS Growth
- GEVO N/A
- TKNO N/A
- EPS
- GEVO N/A
- TKNO N/A
- Revenue
- GEVO $80,187,000.00
- TKNO $38,923,000.00
- Revenue This Year
- GEVO $909.99
- TKNO $9.52
- Revenue Next Year
- GEVO $22.37
- TKNO $15.20
- P/E Ratio
- GEVO N/A
- TKNO N/A
- Revenue Growth
- GEVO 341.75
- TKNO 11.40
- 52 Week Low
- GEVO $0.67
- TKNO $4.00
- 52 Week High
- GEVO $3.39
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- GEVO 57.77
- TKNO 43.35
- Support Level
- GEVO $1.54
- TKNO $4.22
- Resistance Level
- GEVO $1.86
- TKNO $4.94
- Average True Range (ATR)
- GEVO 0.14
- TKNO 0.29
- MACD
- GEVO 0.01
- TKNO -0.00
- Stochastic Oscillator
- GEVO 31.15
- TKNO 16.75
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.